- TM Capital served as a financial advisor to C.B. Fleet Company, Inc. (“Fleet Laboratories”), a portfolio company of Gryphon Investors, in its sale to Prestige Brands for $825 million
- Fleet Laboratories owns a portfolio of iconic brands in the feminine hygiene, gastrointestinal care and infant care categories including Summer’s Eve®, Fleet®, Pedia-Lax®, Phazyme® and Boudreaux’s®
- The Company’s products, which are sold in over 50 countries worldwide, have an unmatched legacy of trust and efficacy with consumers and medical professionals
- This is the fifth transaction in which TM Capital has advised Fleet Laboratories
Medical Products,
Consumer Packaged Goods (CPG),
Consumer,
Healthcare
|
Mergers & Acquisitions,
Sponsor Related
